Hai V. Nguyen

May 6, 2024 | jamanetwork.com | Hai V. Nguyen |Shweta Mital |Emma E. McGinty |Shawn Bugden

Examining Safer Opioid Supply Policies—Reply British Columbia’s Safer Opioid Supply Policy and Opioid Outcomes Hai V. Nguyen, PhD; Shweta Mital, PhD; Shawn Bugden, PharmD; Emma E. McGinty, PhD Examining Safer Opioid Supply Policies Hudson Reddon, PhD; Paxton Bach, MD; M-J. Milloy, PhD Examining Safer Opioid Supply Policies Owen J. Chen, MSc; Xi Zhang, MSc; Julia X. X.

Apr 10, 2024 | sciencedirect.com | Sâmia Joca |Shweta Mital |Hai V. Nguyen |Luana Barreto Domingos

Cannabis is one of the most commonly used drugs in the world, and the prevalence of use is increasing as legalization of the drug expands for medicinal and non-medicinal purposes (Schulenberg et al., 2021, SAMHSA, 2020). Cannabis is often considered synonymous with delta-9-tetrahydrocannabinol (THC), the primary psychoactive constituent of the plant that is responsible for producing many of its hallmark effects.

Jan 16, 2024 | jamanetwork.com | Hai V. Nguyen |Shweta Mital |Shawn Bugden |Emma E. McGinty

Key PointsQuestion  Was there an association of British Columbia’s Safer Opioid Supply policy with opioid prescribing and opioid-related health outcomes in the first 2 years of implementation?

Oct 12, 2023 | jamanetwork.com | Shweta Mital |Hai V. Nguyen |Justin R Ryder |Francesca Lorraine Lim

Key PointsQuestion  Are antiobesity drugs currently approved for pediatric use cost-effective for treating adolescents with severe obesity? Findings  In this economic evaluation using a microsimulation model, phentermine-topiramate was found to be the most cost-effective treatment. While semaglutide could generate greater weight loss than phentermine-topiramate, its incremental cost per quality-adjusted life-year gained exceeded the commonly used willingness-to-pay threshold.